Daily as of 3 Nov 16:00 ET
- Price
- between the two $140.24 vs 50 $142.34 / 200 $117.19
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 20 Mar 2025 · projected 8 bars out
PTGX | Protagonist TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$140.24
+$0.87 (+0.62%)
Protagonist Therapeutics (PTGX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
The 50 SMA sits above the 200 on the daily, with no cross projected inside the 30 bars Cruxta tracks. On both the weekly and the 4-hour, price sits above the 50 and the 200; on the daily it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $144.85 vs 50 $111.45 / 200 $54.45
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 18 Mar 2024 · projected 9 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- above both $140.24 vs 50 $139.83 / 200 $138.67
- Projection
- 💀Death cross projected in 9 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 17 Mar 2025 · projected 9 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 20 Mar 2025 | 🟨Golden moderate | daily | 8 bars out | Not tested |
| 17 Mar 2025 | 🟨Golden | 4-hour | 9 bars out | — |
| 14 Feb 2025 | 💀Death | daily | 29 bars out | 5 bar cross test |
| 11 Dec 2024 | 💀Death | 4-hour | 23 bars out | — |
| 20 May 2024 | 🟨Golden | 4-hour | 29 bars out | — |
About PTGX
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$82.9M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandmid